Status:
COMPLETED
Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Inhaled corticosteroids (ICS) are often prescribed as a treatment for asthma. However, many individuals who take these medications do not adhere to their prescribed treatment regimen. The purpose of t...
Detailed Description
Asthma is a serious, chronic disease that affects lung function and impairs an individual's ability to breathe normally. ICS reduce airway inflammation and are often prescribed to treat these conditio...
Eligibility Criteria
Inclusion
- Received treatment for asthma in the year prior to study entry
- Received at least one respiratory medication at a Kaiser Permanente Northwest (KPNW) or Kaiser Permanente Hawaii (KPH) outpatient pharmacy in the year prior to study entry
- Continuous Kaiser Permanente membership from the year prior to study entry through study entry
- Willing to participate in the study
Exclusion
- Excluded from primary analyses if fewer than three months of follow-up
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
14064 Patients enrolled
Trial Details
Trial ID
NCT00414817
Start Date
June 1 2007
End Date
October 1 2009
Last Update
January 30 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Health Research/KPH
Honolulu, Hawaii, United States, 96817
2
Center for Health Research-KPNW
Portland, Oregon, United States, 97227